U.S. FDA declines to approve Eli Lilly’s drug to treat eczema

The U.S. Food and Drug Administration (FDA) has declined to approve Eli Lilly’s drug to treat a type of skin disease due to certain findings during an inspection of a contract manufacturer, the drugmaker said on Monday.

Read the full article here

Related Articles